PL3349763T3 - Kompozycja do zastosowania w modulowaniu mikrobioty - Google Patents

Kompozycja do zastosowania w modulowaniu mikrobioty

Info

Publication number
PL3349763T3
PL3349763T3 PL16845808T PL16845808T PL3349763T3 PL 3349763 T3 PL3349763 T3 PL 3349763T3 PL 16845808 T PL16845808 T PL 16845808T PL 16845808 T PL16845808 T PL 16845808T PL 3349763 T3 PL3349763 T3 PL 3349763T3
Authority
PL
Poland
Prior art keywords
composition
microbiota modulation
microbiota
modulation
Prior art date
Application number
PL16845808T
Other languages
English (en)
Inventor
Louise Kristine VIGSNÆS
Bruce Mcconnell
Original Assignee
Glycom A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom A/S filed Critical Glycom A/S
Publication of PL3349763T3 publication Critical patent/PL3349763T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL16845808T 2015-09-14 2016-09-14 Kompozycja do zastosowania w modulowaniu mikrobioty PL3349763T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA201570589 2015-09-14
DKPA201670098 2016-02-24
EP16845808.1A EP3349763B1 (en) 2015-09-14 2016-09-14 Composition for use in microbiota modulation
PCT/IB2016/055466 WO2017046711A1 (en) 2015-09-14 2016-09-14 Synthetic composition for microbiota modulation

Publications (1)

Publication Number Publication Date
PL3349763T3 true PL3349763T3 (pl) 2022-01-03

Family

ID=58288193

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16845808T PL3349763T3 (pl) 2015-09-14 2016-09-14 Kompozycja do zastosowania w modulowaniu mikrobioty

Country Status (6)

Country Link
US (2) US10751354B2 (pl)
EP (1) EP3349763B1 (pl)
DK (1) DK3349763T3 (pl)
ES (1) ES2886951T3 (pl)
PL (1) PL3349763T3 (pl)
WO (1) WO2017046711A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011005681A1 (en) 2009-07-06 2011-01-13 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
JP7182872B2 (ja) 2014-10-29 2022-12-05 グリコム・アクティーゼルスカブ 過敏性腸症候群の治療のための合成組成物および方法
US11040049B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
EP3288389A4 (en) 2015-04-28 2018-10-10 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
WO2018157900A1 (en) * 2017-03-01 2018-09-07 Glycom A/S Synthetic composition for microbiota modulation
EP3606535A4 (en) * 2017-04-07 2020-12-16 Children's Hospital Medical Center TREATMENT OF INFLAMMATORY INTESTINAL DISEASES WITH 2'-FUCOSYL LACTOSE COMPOUNDS
EP3634429A4 (en) 2017-05-09 2020-11-04 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
US11541068B2 (en) 2017-05-24 2023-01-03 Glycom A/S HMO compositions and methods for reducing autism spectrum disorder symptoms
US20200323921A1 (en) * 2017-11-30 2020-10-15 Glycom A/S Human milk oligosaccharides and synthetic compositions thereof for microbiota modulation
KR20200096263A (ko) 2017-11-30 2020-08-11 글리콤 에이/에스 밀 민감증을 치료하기 위한 hmo 혼합물
BR112020009257A2 (pt) * 2017-12-21 2020-10-20 Société des Produits Nestlé S.A. composições que compreendem pelo menos um oligossacarídeo n-acetilado e pelo menos um oligossacarídeo fucosilado para uso na promoção da capacidade digestiva em bebês e crianças pequenas
US11484547B2 (en) * 2018-01-08 2022-11-01 Performance Labs PTE. LTD. Compositions and methods for cholesterol, glucose and microbiome control
GB201806941D0 (en) * 2018-04-27 2018-06-13 Ip Science Ltd Methods for improving the microbiome and its systemic effect
KR20210016557A (ko) 2018-05-31 2021-02-16 글리콤 에이/에스 자가면역 질환 치료를 위한 hmo 혼합물
EP3897205A1 (en) 2018-12-21 2021-10-27 Société des Produits Nestlé S.A. A nutritional composition comprising 6'sl and lnt in combination to improve the gastrointestinal barrier function
WO2020126726A1 (en) 2018-12-21 2020-06-25 Societe Des Produits Nestle S.A. A nutritional composition comprising 2'-fucosyllactose (2' fl) to improve the gastrointestinal barrier
US20220022515A1 (en) * 2019-02-25 2022-01-27 Nutribam Bv Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
EP3976051A1 (en) * 2019-05-29 2022-04-06 FrieslandCampina Nederland B.V. Compositions comprising 2 -fucosyllactose and gos
WO2020239726A1 (en) * 2019-05-29 2020-12-03 Frieslandcampina Nederland B.V. Non-therapeutic methods for maintaining a healthy body weight or losing body weight
JP2022535718A (ja) * 2019-06-05 2022-08-10 グリコム・アクティーゼルスカブ 非セリアック小麦及び／又はグルテン過敏症を患っている患者の症状の処置において使用するためのヒトミルクオリゴ糖
CN114728015A (zh) * 2019-11-14 2022-07-08 格礼卡姆股份公司 用于平衡肠中胆汁酸谱的合成组合物
CN112870232A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99提升肠道细菌感染抗性和肠道免疫力的应用
JP2023518058A (ja) * 2020-03-16 2023-04-27 ミガリス アンパーツゼルスカブ ヒト対象でウロリチンの産生を増強するための組成物
CA3210075A1 (en) 2021-04-13 2022-10-20 Petronella Johanna Looijesteijn Nutritional composition for stimulationg bifidobacteria

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227777A (ja) 1985-04-02 1986-10-09 Showa Sangyo Kk ビフイズス菌生育活性剤
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
ES2456292T3 (es) 2006-03-09 2014-04-21 Centre National De La Recherche Scientifique (Cnrs) Procedimiento de producción de oligosacáridos sialilados
AU2010223965A1 (en) * 2009-03-13 2011-10-06 Dsm Food Specialties Usa Inc. Prebiotic oligosaccharides
WO2010115935A1 (en) 2009-04-07 2010-10-14 Glycom A/S Synthesis of 2 ' -o-fucosyllactose
BR112012020791A2 (pt) 2010-02-19 2016-05-03 Glycom As produção de 6'-o-sialillactose e intermediários
US8993740B2 (en) 2010-02-19 2015-03-31 Glycom A/S Method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt) containing N-acetyllactosamine
KR20140011296A (ko) 2010-07-16 2014-01-28 글리콤 에이/에스 올리고당의 유도체화
MY165628A (en) * 2010-12-31 2018-04-18 Abbott Lab Human milk oligosaccharides for modulating inflammation
EP3335577A1 (en) * 2010-12-31 2018-06-20 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
BR112013015951A2 (pt) * 2010-12-31 2018-07-10 Abbott Lab composições nutricionais compreendendo oligossacarídeos e nucleotídeos de leite humano e usos destas para tratar e/ou prevenir infecção viral entérica.
CN103429604A (zh) 2011-02-21 2013-12-04 格礼卡姆股份公司 寡糖前体的混合物的组合物的催化氢解及其用途
WO2012127410A1 (en) 2011-03-18 2012-09-27 Glycom A/S Synthesis of new fucose-containing carbohydrate derivatives
JP2014513985A (ja) 2011-05-13 2014-06-19 グリコム アー／エス 人乳オリゴ糖（ｈｍｏ）又はその前駆体の形成方法
US20140323705A1 (en) 2011-05-13 2014-10-30 Markus Hederos Manufacture of lacto-n-tetraose
KR20140036226A (ko) 2011-05-13 2014-03-25 글리콤 에이/에스 모유 올리고사카라이드(hmo) 또는 그의 전구체의 다양화
SG2014013478A (en) * 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2760875A4 (en) 2011-09-30 2015-08-26 Glycom As SYNTHESIS OF HMO NUCLEAR STRUCTURES
MX350436B (es) 2011-10-18 2017-09-06 Nestec Sa Composicion para uso en el aumento de sensibilidad a la insulina y/o la reduccion de resistencia a la insulina.
US20150087616A1 (en) 2011-11-30 2015-03-26 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
EP2828275B1 (en) 2012-03-20 2017-03-01 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
CN110679948A (zh) * 2012-12-20 2020-01-14 雅培制药有限公司 使用人乳寡糖用于调节炎症的营养制剂
US10165788B2 (en) * 2013-06-17 2019-01-01 The Regents Of The University Of California Methods and compositions for improved digestion of milk oligosaccharides
JP7182872B2 (ja) 2014-10-29 2022-12-05 グリコム・アクティーゼルスカブ 過敏性腸症候群の治療のための合成組成物および方法

Also Published As

Publication number Publication date
US20210000848A1 (en) 2021-01-07
EP3349763B1 (en) 2021-08-11
WO2017046711A1 (en) 2017-03-23
EP3349763A1 (en) 2018-07-25
US11696921B2 (en) 2023-07-11
US10751354B2 (en) 2020-08-25
DK3349763T3 (en) 2021-11-15
ES2886951T3 (es) 2021-12-21
EP3349763A4 (en) 2019-05-01
US20180185396A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
DK3349763T3 (en) Composition for use in microbiota modulation
HK1257295A1 (zh) 用於免疫腫瘤學的組合物和方法
IL271659A (en) Compositions and methods for modulating expression of complement factor B
GB201411197D0 (en) Composition and use thereof
PT3015526T (pt) Composição à base de hidrofluoroolefina e sua utilização
IL246879B (en) Preparations of Epilimod and methods of using them
SG11201605762QA (en) Block copolymer composition and adhesive composition
IL260017A (en) The lyophilized composition for preserving microbiota in the microbiota ecosystem
SG11201605714VA (en) Block copolymer and adhesive composition
HK1245158A1 (zh) 阿吡莫德組合物及其使用方法
HK1231426A1 (zh) 皮膚增白美容組合物
SI3220893T1 (sl) Sestavek na osnovi COQ10
GB201410506D0 (en) Hybrid composition
SG11201702475VA (en) Methods and compositions for modulating th-gm cell function
GB201519326D0 (en) Composition`
GB201411196D0 (en) Composition and use thereof
HK1231379A1 (zh) 毛髮組合物
HK1257847A1 (zh) 化妝品組合物
HK1247082A1 (zh) 化妝品組合物
EP3344738A4 (en) COMPOSITION FOR USE IN OILS
RS56048B1 (sr) Usavršene kompozicije i postupci za fruktoboratne komplekse
PL2990058T3 (pl) Ulepszone kompozycje i sposoby dla kompleksów fruktoboranowych
GB201411371D0 (en) Immunogenic composition
GB201411306D0 (en) Immunogenic composition
GB201404391D0 (en) Novel compositions having use in therapy